investigating the association between serum pro- and anti-inflammatory cytokines concentration and in-stent sestenosis: a case control study

Introduction : it has been shown that angioplasty and endovascular stent deployment, used after coronary revascularization, are associated with an inflammatory response. inflammation has a key role in the complications of atherosclerotic plaque, coronary artery disease (cad) and in-stent restenosis (isr). the objectives of the present study was to investigate serum levels of 12 pro/anti-cytokines and growth factors and their relationship with restenosis.methods: a total of 244 subjects were recruited in current study including unrelated patients who previously underwent coronary stent implantation (between 2014 and 2017) and were subsequently indicated for coronary angiography. according to angiography results patients were allocated into two groups: cases with stenosis more than 50% within the stent (n=79) and controls with stenosis less than 50% within the stent (n=165). serum was separated by centrifuging the blood for 15 min at 1000 rpm.  serum cytokines levels including il-1α, il-1β, il-2, il-4, il-6, il-8, il-10, tnf-α, ifn-γ, mcp-1, egf, and vegf were measured using an ev 3513 cytokine biochip array (randox laboratories, crumlin, uk).results: the mean age of the nisr and isr groups were 62.47±9.2 and 59.49±8.48 years, respectively. the diabetes frequency was significantly higher in the isr group (55.1%) compared with nisr group (30.9%) (p<0.001). there was no significant difference in levels of cytokines between the two groups (p>0.05).conclusions: the results showed that serum levels of pro/anti-inflammatory cytokines and growth factors did not have a significant difference between nisr and isr study groups.